Background: This study used a meta-analysis to quantify the degree to which the racial disparity in overall survival for black versus white Americans with oropharyngeal squamous cell carcinoma (OPSCC) persists after adjusting for human papillomavirus (HPV) status. Methods: PubMed/MEDLINE, Cochrane Database of Systematic Reviews, and CINAHLA were searched through November 2017. The PRISMA statement was followed. The pooled hazard ratio (HR) was calculated using a random-effects model. Results: Five studies met the inclusion criteria and had suitable data for pooling into the meta-analysis (N = 1153). The pooled HR for overall survival in black versus white Americans with OPSCC after adjusting for HPV status was calculated to be 1.45 (95% confidence interval, 0.87-2.40). Conclusions: The difference in survival for black versus white Americans with OPSCC is not significant after adjusting for HPV status but still trends in the direction of a disparity. Additional studies are needed to better characterize this disparity.
| INTRODUCTION
Much of current literature acknowledges a disparity in overall survival between black and white patients with oropharyngeal squamous cell cancer (OPSCC). 1 Many factors have been implicated in the reason for disparity, including higher stage at presentation, comorbidities, socioeconomic status, treatment differences, and human papillomavirus (HPV) status. 2, 3 The relative contribution of HPV status to overall survival of OPSCC, compared to other risk factors, has been a topic of controversy. This meta-analysis quantifies the contribution of HPV status to the racial disparity seen in overall survival of OPSCC, and it discusses other potentially modifiable factors that may drive the disparity.
The ongoing effort to define the relationship between race, HPV status, and survival in OPSCC emerges from a body of research that first identified racial disparities in overall survival and stage at presentation for cancers of the head and neck. [2] [3] [4] [5] [6] [7] Further investigation elucidated that poverty is an independent predictor of poor survival in head and neck cancer, with significantly more African Americans than whites living in an impoverished community. 8 Another study of patients with oropharyngeal and oral cavity cancer found the odds for not being recommended for surgery is twice as high among black patients compared to white patients. 7 Socioeconomic status, treatment modalities, and other factors that affect access to care are all likely to impact the racial disparity seen in overall survival of OPSCC. Settle et al was one of the first studies to suggest that the racial disparities observed in head and neck cancers are largely driven by the oropharyngeal subsite, and moreover, a low prevalence of black compared to white patients with HPV-positive OPSCC. 9 Since then, it has become well established that a positive HPV tumor status has a positive prognostic impact for patients with OPSCC. 10 Furthermore, a recent epidemiological study of patients with OPSCC and known HPV status in the United States (n = 22 693) found that 67.6% of white patients were HPV-positive compared to 42.3% of African American patients (P < .001). 11 The prognostic impact of HPV status combined with the prevalence difference in black versus white patients can at least partially account for disparities in overall survival of OPSCC. 2, [12] [13] [14] [15] To develop targeted public health interventions, it is important to understand the relative degree that HPV status, compared to other risk factors, contributes to the observed racial disparity.
The aim of this investigation is twofold: (1) to pool current data into a meta-analysis that quantifies the degree to which racial disparities may persist after accounting for HPV status, and (2) discuss other possible factors that may contribute to this disparity, based on evidence from current literature.
| METHODS

| Literature search
A literature search was conducted through November 2017 using PubMed/MEDLINE, Cochrane Database of Systematic Reviews, and CINAHLA to find studies assessing the role of race and HPV status in overall survival for patients with OPSCC. The following MESH terms and relevant keywords were used in the search: oropharyngeal cancer, health status disparities, racial disparities, health disparities, race, racial, African Americans, papillomavirus, and HPV. Reference lists were reviewed for additional articles. The Preferred Reporting Items for Systemic Reviews and Meta-Analyses (PRISMA) statement was followed.
Titles and abstracts of the studies retrieved using the search strategy were screened independently by three review authors (N.L., D.F., A.M.) to identify studies that potentially met the inclusion criteria. The full-texts of these identified studies were independently assessed for eligibility by two review authors (N.L. and D.F.). Any disagreement between the review authors over the eligibility of a particular study was resolved by discussion with a fourth reviewer (J.Z.).
| Inclusion and exclusion criteria
Articles were included in the meta-analysis if they were written in English, conducted in the United States, and assessed overall survival in black versus white patients with OPSCC and known HPV status.
The following additional inclusion criteria were applied for the meta-analysis: (1) must be a cohort study that uses a multivariable Cox regression to obtain a hazard ratio for overall survival in black versus white patients with oropharyngeal cancer, (2) the multivariable analysis must adjust for HPV status, (3) the multivariable analysis must have a minimum number of 50 patients (N ≥ 50), and (4) the study must use an accepted method for HPV testing, including HPV DNA in situ hybridization (ISH), HPV DNA PCR, or p16 immunohistochemistry.
Studies that were conducted by the same authors and found to have a duplication of the patient population were excluded. Additionally, studies that were conducted by different authors but had overlapping populations were excluded.
| Quality assessment and data extraction
Quality of the eligible studies was assessed independently by two review authors (N.L. and M.M.) using the Joanna Briggs Institute Critical Appraisal Tool Checklist for Cohort Studies. There were 11 items on the critical appraisal checklist, so cut-off scores between 1 and 11 were established to gauge study quality. Scores 1-4 represented low quality, scores 5-8 represented moderate quality, and scores 9-11 represented high quality. Data from eligible studies was independently extracted into a table by two review authors (N.L. and M.M.). Extracted information included population size and characteristics, HPV testing method, adjusted hazard ratio with 95% confidence interval, and adjustment set. Email correspondence was used to contact authors of studies with any relevant missing data.
| Statistical analysis
Calculations and plot syntheses were conducted using the R statistical computing software (version 3.3.1). The hazard ratio for overall survival in black versus white patients with OPSCC, adjusted for HPV status, was calculated using a random-effects model. A forest plot was generated. Heterogeneity was calculated using the I 2 statistic. Publication bias was assessed using funnel plot techniques with the Eggerweighted-linear-regression method.
3 | RESULTS
| Search results
The initial literature search yielded 100 articles. Four additional articles were identified by reviewing the reference lists in these articles. Three review authors (N.L., D.F., and A.M.) independently screened the titles and abstracts of the 104 articles. One duplicate was removed. Sixteen articles were excluded for being conducted outside of the United States; additionally, none of these international studies met the inclusion criteria for assessing black versus white racial disparities in overall survival. Nineteen articles were excluded for not addressing both HPV status and oropharyngeal cancer. Twenty articles were excluded for not assessing black versus white racial disparities in overall survival. The remaining 48 full-text articles were independently assessed for eligibility by two review authors (N.L. and D.F.). Thirty nine articles were excluded for not using a cohort study with a multivariable Cox regression to assess for overall survival differences after adjusting for HPV. One study was excluded for not having a minimum number of 50 patients. Three studies were excluded for having overlapping patient populations. Five studies remained to be included in the metaanalysis ( Figure 1) . These five remaining studies had suitable data for pooling (N = 1153). Ang et al study calculated the adjusted hazard ratio for overall survival in "nonwhites" versus whites. 18 To generalize these results to our meta-analysis, which sought to analyze racial disparities in black versus white Americans, we contacted the authors of this article via email correspondence to verify the specific number of black versus white patients. We were unable to obtain these specific numbers from the Ang et al study, but we performed a sensitivity analysis to determine if the results of the meta-analysis would change after excluding this study. 18 We found that exclusion of this study did not change the significance of the results. The pooled HR was 1.39 (95% confidence interval, 0.69-2.91) when the study was excluded. Therefore, we decided to include the Ang et al study in the meta-analysis. 18 We recognize this as a potential limitation. 
| Quality assessment and data extraction
| Publication bias
Publication bias was illustrated using a precision funnel plot ( Figure 2) . A non-significant Egger regression intercept was found (P = .88). Heterogeneity was calculated as an I 2 value of 67%. Heterogeneity between studies was statistically significant (P = .02), reflecting differences in the effect size seen across the five studies. For this reason, a random-effects model was chosen for the meta-analysis.
| Meta-analysis
The meta-analysis yielded a pooled HR of 1.45 (95% CI, 0.87-2.40), which represents the hazard of death in black versus white Americans with OPSCC after adjusting for HPV status (Figure 3 ). To quantify how much of the overall survival disparity can be explained by HPV status, we compared our pooled HR to the unadjusted HR as determined from the SEER database. In an analysis of 13 434 patients diagnosed with OPSCC between 2004 and 2012, Megwalu et al calculated an unadjusted HR of 1.67 (95% CI, 1.54-1.81) in black versus white Americans. 19 The adjustment set for this study included age, sex, marital status, tumor site, and year of diagnosis.
| DISCUSSION
Compared to the unadjusted HR of 1.67 (95% CI, 1.54-1.81) from the SEER database, our pooled HR of 1.45 (95% CI, 0.87-2.40) adjusted for HPV status suggests that much of the disparity in survival between black and white Americans with OPSCC can be explained by differences in HPV status.
In our meta-analysis, the survival disparity is not statistically significant after adjusting for HPV status. This result must be interpreted with caution, however, given the small number of studies that were suitable for inclusion (N = 5) and the significant heterogeneity (I 2 = 67%, P = .02) among the studies. More population studies are needed before we can draw strong conclusions about the persistence of survival disparities in OPSCC after adjusting for HPV status.
While the meta-analysis yields a survival disparity that is no longer significant after adjusting for HPV status, the 95% confidence interval still trends in the direction above one. This trend may be partly attributable to racial differences in socioeconomic variables, especially given that none of the five studies in the meta-analysis controlled for these. Furthermore, there is evidence in current literature to suggest that differential access to care and socioeconomic status contribute to racial disparities in head and neck cancer. 7, 8, 20, 21 In a study of 20 915 patients with head and neck cancer, Molina et al demonstrated that poverty is an independent predictor of poorer survival outcomes, and that significantly more African Americans than whites live in a community in which at least 15% of the local population is below the poverty line (P = .001). 8 Similarly, Reitzel et al found significantly poorer survival outcomes in oropharyngeal cancer patients from highly deprived neighborhoods compared to those from less deprived neighborhoods (HR = 1.59; 95% confidence interval, 1.00-2.53). 22 Hollenbeak et al found that in Medicare patients with pharyngeal cancers (n = 3987), black patients accumulated $25 093 (95% confidence interval, $14 917-$34 985) more in medical costs over 5 years than white patients, even after controlling for comorbidities. Socioeconomic variables at both the individual and neighborhood level have implications across the spectrum of cancer care and can manifest as racial disparities in survival outcomes.
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This meta-analysis is greatly limited by the small number of studies that met inclusion criteria (N = 5) and the significant heterogeneity (I 2 = 67%, P = .02) among the studies. The use of "non-whites" in the Ang et al study was found to be nonsignificant based on a sensitivity analysis, but the inclusion of this study may still limit the generalizability of the meta-analysis. 18 Additionally, only one of the five studies adjusted for alcohol use and none of the studies adjusted for socioeconomic variables, which are potential confounders. Collectively, these limitations can be addressed in the future with more population studies that assess racial disparities and HPV status in oropharyngeal cancer. Ideally, future studies should include very specific demographic characteristics of the populations being analyzed as well as comprehensive adjustment sets. While we are unable to draw strong conclusions about the persistence of racial disparities from this meta-analysis, we do provide an estimate of the pooled HR adjusted for HPV status that is stronger than any individual study alone. Individual studies have yielded a wide range of outcomes (adjusted HR's ranging from 0.87 to 2.57), and this has contributed to the lack of consensus in current literature about the true contribution of HPV status to racial disparities in OPSCC. 10, 16 The variability among individual studies may be partly attributable to small differences in adjustment sets and measurement methods. However, it may also represent differences in socioeconomic status and access to care of the populations being sampled. For example, the populations sampled from tertiary-care cancer centers and VA hospitals are likely to have slightly different sets of exposures as well as different exposure-race relationships. Since race represents a complex combination of exposures that likely varies by geographic population, it is important to study disparities across a wide range of settings and adjust for socioeconomic variables. This meta-analysis pools data from diverse geographic populations to generate a more representative HR than previously available in literature; however, it also illustrates the need for more studies on racial disparities in OPSCC, especially studies that address socioeconomic variables in the adjustment sets.
| CONCLUSIONS
It is important to quantify the degree to which differences in HPV prevalence, relative to other risk factors, contribute to the racial disparities seen in OPSCC to guide public health strategies. Variation in results across individual studies has contributed to a lack of consensus on the issue. A metaanalysis was conducted to quantify the contribution of HPV status to racial disparities in OPSCC. The pooled HR shows that the disparity in overall survival for black versus white Americans with OPSCC is not significant after adjusting for HPV status, but it still trends in the direction of a disparity.
In conclusion, much of the survival disparity in OPSCC can be attributed to racial differences in HPV status, but continued efforts are needed to further characterize this disparity. 
